BioCardia's President to Present at H. C. Wainwright 27th Annual Global Investment Conference.

BioCardia's President and CEO, Peter Altman, PhD, will present a corporate update at the H. C. Wainwright 27th Annual Global Investment Conference. He will discuss the company's progress toward milestones, including its three clinical cell therapy programs for ischemic heart disease and regulatory activities seeking FDA and Japan PMDA approval for CardiAMP cell therapy for heart failure. Additionally, he will detail the recent partnership to develop and commercialize Heart3D fusion imaging and the status of the nondilutive funding for CardiALL.

BioCardia, Inc. [NASDAQ:BCDA], a leading developer of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, has announced that its President and CEO, Peter Altman, PhD., will present a corporate update at the H. C. Wainwright 27th Annual Global Investment Conference. The event will take place from September 8-10, 2025, at the Lotte New York Palace Hotel in New York City.

Dr. Altman will present in person at 2:00 PM ET on Wednesday, September 10, 2025. He will discuss the company's progress towards various milestones, including its three clinical cell therapy programs for ischemic heart disease. Additionally, he will provide updates on regulatory activities seeking FDA approval and Japan PMDA approval for CardiAMP® cell therapy for heart failure.

The presentation will also cover the recent partnership to develop and commercialize Heart3D fusion imaging and the status of the nondilutive funding for the CardiALLO™ allogeneic mesenchymal stem cell program for the treatment of heart failure. Dr. Altman will be available for one-on-one meetings with investors during the conference.

The H. C. Wainwright Global Investment Conference is a prominent event for investors and financial professionals, offering insights into various sectors, including biotechnology. For more information about the conference, visit [H. C. Wainwright Global Investment Conference](https://hcwevents.com/annualconference/).

References:
[1] https://www.stocktitan.net/news/BCDA/bio-cardia-ceo-peter-altman-to-present-at-the-h-c-wainwright-27th-px6max5jkxjx.html